articleNew England Journal of MedicineMar 30, 2005BRONZE OA

Comparison of Warfarin and Aspirin for Symptomatic Intracranial Arterial Stenosis

Emory University · Icahn School of Medicine at Mount Sinai · +6 more institutions

Indexed incrossref

Abstract

Atherosclerotic intracranial arterial stenosis is an important cause of stroke. Warfarin is commonly used in preference to aspirin for this disorder, but these therapies have not been compared in a randomized trial.We randomly assigned patients with transient ischemic attack or stroke caused by angiographically verified 50 to 99 percent stenosis of a major intracranial artery to receive warfarin (target international normalized ratio, 2.0 to 3.0) or aspirin (1300 mg per day) in a double-blind, multicenter clinical trial. The primary end point was ischemic stroke, brain hemorrhage, or death from vascular causes other than stroke.After 569 patients had undergone randomization, enrollment was stopped because of…

Citation impact

1,728
total citations
FWCI
66.95
Percentile
100%
References
45
Citations per year

Authors

13

Topics & keywords

Keywords
  • Medicine
  • Warfarin
  • Aspirin
  • Hazard ratio
  • Stroke (engine)
  • Confidence interval
  • Internal medicine
  • Stenosis
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.